Literature DB >> 14530332

Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.

Honglin Xu1, Taehoon Chun, Angela Colmone, Hanh Nguyen, Chyung-Ru Wang.   

Abstract

Although CD1d and MHC class Ia share similar overall structure, they have distinct levels and patterns of surface expression. While the expression of CD1d1 is known to be essential for the development of NKT cells, the contribution of CD1d1 to the development of CD8(+) T cells appears to be inconsequential. To investigate whether CD1d tissue distribution and expression levels confer differential capacity in selecting these two T cell subsets, we analyzed CD8 and NKT cell compartments in K(b)-CD1d-transgenic mice that lack endogenous MHC class Ia and CD1d, respectively. We found that MHC class Ia-like expression pattern and tissue distribution are not sufficient for CD1d to rescue the development of CD8(+) T cells, suggesting that unique structural features of CD1d preclude its active participation in selection of CD8(+) T cells. Conversely, cell type-specific CD1d surface density is important for the selection of NKT cells, as the NKT cell compartment was only partially rescued by the K(b)-CD1d transgene. We have previously demonstrated that increased CD1d expression on dendritic cells enhanced negative selection of NKT cells. In this study, we show that cell type-specific expression levels of CD1d establish a narrow window between positive and negative selection, suggesting that the distinct CD1d expression pattern may be selected evolutionarily to ensure optimal output of NKT cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14530332     DOI: 10.4049/jimmunol.171.8.4105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.

Authors:  Xiufang Weng; Ying He; Lavanya Visvabharathy; Chia-Min Liao; Xiaosheng Tan; Arjun Balakumar; Chyung-Ru Wang
Journal:  J Hepatol       Date:  2017-07-14       Impact factor: 25.083

2.  Transcriptional control of invariant NKT cell development.

Authors:  Rupali Das; Derek B Sant'Angelo; Kim E Nichols
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

3.  CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.

Authors:  Cheng Ye; Benjamin E Low; Michael V Wiles; Todd M Brusko; David V Serreze; John P Driver
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

4.  Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2007-04

5.  All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Immunobiology       Date:  2014-09-16       Impact factor: 3.144

6.  CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice.

Authors:  Jun-Qi Yang; Taehoon Chun; Hongzhu Liu; Seokmann Hong; Hai Bui; Luc Van Kaer; Chyung-Ru Wang; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

7.  Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.

Authors:  Datsen G Wei; Hyunji Lee; Se-Ho Park; Lucie Beaudoin; Luc Teyton; Agnès Lehuen; Albert Bendelac
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

Review 8.  SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function.

Authors:  Devika Bahal; Tanwir Hashem; Kim E Nichols; Rupali Das
Journal:  Int J Mol Sci       Date:  2019-09-27       Impact factor: 5.923

Review 9.  Antitumor Responses of Invariant Natural Killer T Cells.

Authors:  Jennie B Altman; Adriana D Benavides; Rupali Das; Hamid Bassiri
Journal:  J Immunol Res       Date:  2015-10-12       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.